Is Cancer Quackery Dead?

The amount of money wasted on cancer quackery is unknown but probably exceeds one billion dollars per year -- the amount spent for cancer research.

According to Dr. Jarvis is Professor of Public Health and Preventive Medicine, School of Medicine and Public Health, Loma Linda University, and President of the National Council Against Health Fraud, some of the worst quackery-related tragedies result from delay or failure to act. An example of a needless death involved an Oregon man who treated his basal cell carcinoma of the mouth with a mail-order remedy for 15 years. What makes this case especially tragic is that since this type of cancer almost never metastasizes, he had many years in which to correct his folly. Although badly disfigured by the growing tumor, he continued self-treatment.

Overreliance upon dietary treatment is a common means by which indirect harm kills cancer sufferers. A health food store owner discovered a lump in her breast. After diagnosing it as cancer, she boasted to her health food friends that she was "going to prove once and for all that diet cure works!" Unfortunately, although at least 80% of self-discovered breast lumps are benign, hers was cancerous. Her husband looked after her for more than a year before the lesion became so gross and her pain so unbearable that she asked to be taken to a doctor for the first time. She died five days later.

For more information, go to http://www.quackwatch.com/

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap